SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Contrarian Investing -- Ignore unavailable to you. Want to Upgrade?


To: gcrispin who wrote (188)9/16/2006 7:50:12 PM
From: jsabelko  Respond to of 4080
 
gcrispin,

Agreed. Question for me is that regardless of the conflicts if this year various agencies overspent in support of the war efforts and were forced to delay otherwise intended purchases from ezen then these agencies could still spend for planned purchases at beginning of next year's budget and there may be pent up demand. Regardless, it's all speculation at this point. Thanks.

I do like imos and have reviewed their latest presentations. If I'm looking at their financials correctly there are a couple items that make them not quite as ridiculously undervalued as they appear at first glance: 1/3 minority interest, extraordinary gain last quarter 9 million. Still even considering this they do appear undervalued and I thank you for bringing it to my attention.

joby



To: gcrispin who wrote (188)9/20/2006 6:19:29 PM
From: fedman  Respond to of 4080
 
I noticed that you mentioned MEDX. I have a brother who works there. PHd in Genetics. He's been in several biotechs and he likes what's in the pipeline at MEDX. Feel free to contact me if you want to find additional info about the company.